此课题是由苏州医学院血栓与止血研究室阮长耿教授等申请并进行研究的。他们应用杂交瘤技术在国内首次成功地获得了14株抗人血小板单克隆抗体,其中SZ-2和SZ-21两株,经免疫和生化研究技术证明,分别作用于血小板膜糖蛋白Ⅰ和糖蛋白Ⅲ。此项研究不仅对阐明血小板膜受体,特别是血小板膜糖蛋白的结构与功能以及血小板活化的机制等基础研究提 This topic is from the Suzhou Medical College Thrombosis and Hemostasis Laboratory, Professor Ruan Changgeng apply and conduct research. They used hybridoma technology for the first time in China successfully obtained 14 anti-human platelet monoclonal antibodies, SZ-2 and SZ-21 two strains, the immune and biochemical studies have shown that the role of platelet membrane glycoprotein Ⅰ and sugar Protein Ⅲ. This study not only elucidates the basic research on the structure and function of platelet membrane receptors, especially platelet glycoproteins, and the mechanism of platelet activation